Zansors joins roundtable with President Obama, moderated by MSNBC’s Chris Matthews

Zansors discusses small business access to global markets on a panel with the president

TYSONS, Va. (April 22, 2015) - Zansors joined President Obama Tuesday in a roundtable discussion about the Trans-Pacific Partnership (TPP) and how it will affect small business and jobs in the U.S. Abhijit Dasgupta, PhD, Chief Data Science Officer and Co-Founder of Zansors, participated in the discussion alongside U.S. Rep. Gerry Connolly and others local business leaders. The panel was moderated by MSNBC’s Chris Matthews on Hardball. (View the segment here.)

The President covered the importance of passing trade promotion authority to pave the way for new, high-standards trade agreements that put American workers first and help American businesses expand. Discussion on the roundtable included how opening up new markets to American goods and services can benefit workers and businesses alike.

The TPP places special attention to both intellectual property (IP) and digital commerce, allowing for a meaningful agreement to help small business like Zansors access global markets. What could the TPP mean for a company like Zansors?

• Delivering new uses of health technology to the markets that need it most
• Entering markets with fewer barriers, allowing for faster growth and new hires
• Capturing revenue that can be reinvested into innovation

The most important opportunity is the ability to affect lives all over the world.  For example, Zansors’ current breathing sensor platform can be used to better identify pneumonia in children under the age of five. Current methods are based on manually counting breaths with the human eye - but through automated tools, Zansors can measure breaths objectively with sound capture. With fewer barriers, Zansors could bring this life-saving product to Asia.

“Building these products are no easy task. Zansors needs integrated teams in bioengineering, data science, design, software programming, testing, and so on - all talent found here in the U.S.,” said Dr. Dasgupta. “Growing efficiently will allow Zansors to create new inventions and IP, but creating that future requires mastery of IP on a global scale. Eliminating roadblocks through TPP could be transformative for small businesses like Zansors.”

Zansors is honored to have been selected for the roundtable with President Obama. Trade and global markets are essential for the U.S. economy to thrive and for our country to continue to bring technology and innovation to the world. 

About Zansors

Zansors is a small business that makes micro/nano sensor technologies and evidence-based medical mobile apps so you can gain personal health analytics and “know yourself.”  Our sensors and medical app solutions are have gone through peer-review panels and funded by contracts and grants from different institutes at the National Institutes of Health (NIH) under the Small Business Innovation Research (SBIR) program. In addition for these innovations, Zansors has partnered with notable universities to address breast cancer, sleep disorders, and water safety.  

Zansors’ Chief Data Science Officer to speak at mHealth Summit 2014

Tysons, VA, December 3, 2014 -- Zansors’ Chief Data Science Officer Abhijit Dasgupta, PhD has been announced as a speaker at mHealth Summit 2014. Dr. Dasgupta will speak in the session Conditional Management with Mobile and Connected Health, on "Real-time monitoring of lymphedema using self-reporting, sensors and mobile technologies".

Dr. Dasgupta is the lead scientist on Zansors Cancer Survivor Symptom Tracker, a project funded by the National Cancer Institute’s (NCI) SBIR Contract Program. Women who have undergone surgery or radiation for breast cancer are prone to lymphedema, swelling caused by fluid retention in the lymph nodes. Often they don’t see their doctors until symptoms become debilitating. Zansors Cancer Survivor Symptom Tracker allows these women to:

• Quickly and easily input data on symptoms and quality of life on their smart phones or tablets
• Send data to caregivers, from mobile devices and wearable sensors, using a HIPAA-compliant cloud-based system
• Receive encouraging prompts to collect data or notifications to “see doctor,” before a crisis develops
• Communicate complete health stories—as opposed to relying on memory during short, sporadic doctor visits

Dr. Dasgupta’s Co-Principal Investigator is Kathryn H. Schmitz, PhD, MPH, Professor of Epidemiology in Biostatistics and Epidemiology at the University of Pennsylvania Perelman School of Medicine.

What: Conditional Management with Mobile and Connected Health

When: Monday, 12/08/2014 11:00AM -12:00PM

Where: Room National Harbor 10-11

About Zansors

With our credo of “know yourself” Zansors® endorses a patient-centric health model. We believe that better health and wellness comes only when you know your health habits and symptoms, as they occur over time – not just when you see your doctor. Our evidence-based apps, sensors and digital tracking tools empower you to collect personal health data easily and affordably. So your health care decisions become clear, accurate, and relevant — based on you, not on someone like you. For more information please click here.

About the Conference

The largest event of its kind, the mHealth Summit gathers a uniquely diverse international delegation, including healthcare technology officials in government and industry; policymakers; academic researchers and students; healthcare providers; entrepreneurs; investors; public health and safety officials and patient advocates from across mobile and connected health. For additional information please click here.

Zansors to Co-Present at the Next Generation Dx Summit

Baabi Das, Founder and President of Zansors, will be co-presenting a session on Enabling Point-of-Care Diagnostics at the Next Generation Dx Summit with Zhenyu Li, Ph.D., Assistant Professor, School of Engineering and Applied Science, George Washington University on Tuesday, August 19th 2014. The pair will present and discuss recent microfluidic technology developments in the laboratories of George Washington University that are being commercialized by Zansors to offer next-generation tools for realizing both medical tricorder-like handheld in vitro diagnostic (IVD) systems and wearable lab-on-a-chip systems. Additionally a fully automated handheld immunoassay system will be discussed as well as a bendable, stretchable microfluidic system based on oxidative stress and other biomarkers.

Zhenyu Li, Ph.D., focuses his work on the integration of nanophotonics and microfluidics, or Optofluidics, for life sciences and medicine, particularly single cell analysis for stem cell and cancer research, and portable integrated biosensors for point-of-care diagnostics, environmental monitoring and food safety inspection. He earned his Ph.D. in Electrical Engineering from the California Institute of Technology.

About the Next Generation Dx Summit

Access to next generation diagnostics will only be gained through careful creation and management of partnerships in the community around development, commercialization, reimbursement and regulation. This year’s Next Generation Dx Summit will showcase advances in personalized medicine through a comprehensive program encompassing companion diagnostics, infectious disease, cancer molecular markers, point-of-care, inherited disorders, cell-free DNA and single-cell sequencing. This event has become the meeting place for major players in the expanding arena of diagnostics. It will showcase key components of their successful adoption in the clinic and advancement to the market.

Zansors Named a Semifinalist in LIVESTRONG Foundation’s Inaugural Big C Competition

TYSONS, VA | June 5, 2014 – Zansors selected as a semi-finalist for the 2014 Big C Competition powered by LIVESTRONG

The Big C, powered by LIVESTRONG, announced that Zansors has been selected as a semi-finalist from a field of more than 750+ entries. The Big C is a one-of-a-kind competition to generate innovations that improve the quality of life for the 32.5 million people worldwide living with cancer.

Zansors’ submission is platform including a patient app and clinician dashboard that digitally monitors patient quality of life for breast cancer survivors. It captures patient self-reported data as well as behavioral and lifestyle indicators relevant to lymphedema, and combines this with data collected from a wearable tracking sensor.

"I'm delighted with the response we're getting to this platform,” said Jill MacNeice, Zansors Chief Experience Officer. “We are committed to improving outcomes for cancer survivors. Digital self-tracking, which can be done easily and in the moment, is an important tool to help survivors gain a better quality of life."

Semi-Finalists are competing for $140,000 in seed funding, mentoring and global exposure to a community of potential customers and investors to develop programs, services, new technology and inventions that improve cancer patients' and survivors' daily life.

"The Big C Competition has the potential to bring our platform to survivors of other types of cancer and to those facing other diseases on a much quicker timeline," said Jason Waxberg, Zansors Chief Growth Officer. "Knowing that our evidence based, patient-centric solutions can improve a patient's quality of life is a powerful motivator for us not only in this competition but in everything we do."

The Big C will announce the companies moving on to the next round on July 14.

About Zansors

With our credo of “know yourself” Zansors® endorses a patient-centric health model. We believe that better health and wellness comes only when you know your health habits and symptoms, as they occur over time – not just when you see your doctor. Our evidence-based apps, sensors and digital tracking tools empower you to collect personal health data easily and affordably. So your health care decisions become clear, accurate, and relevant —based on you, not on someone like you. For the latest news be sure to follow Zansors on twitter.

About the LIVESTRONG Foundation

The LIVESTRONG Foundation fights to improve the lives of people affected by cancer now. Created in 1997, the Foundation is known for providing free cancer support services and advocating for policies that improve access to care and quality of life. Known for its powerful brand – LIVESTRONG – the Foundation has become a symbol of hope and inspiration around the world. Since its inception, the Foundation has served 2.5 million people affected by the disease and raised more than $500 million to support cancer survivors. One of America's top non-profit organizations, the Foundation has been recognized by industry leaders including Charity Navigator, the National Health Council and the Better Business Bureau for its excellent governance, high standards and transparency. For more information, visit LIVESTRONG.org.

Zansors selected for ATA's Venture Summit and Innovation Spotlight May 18 -19, 2014

Zansors has been chosen as a presenting company for the American Telemedicine Assoication's (ATA) Venture Summit on May 18, 2014 and Zansors will present during ATA's Innovation Spotlight on May 19, 2014.

Read the press release about the ATA Venture Summit here: http://www.jonesday.com/ata-telemedicine-venture-summit-05-18-2014/

More information about the ATA Innovation Spotlight is here: http://www.americantelemed.org/ata-2014/educational-program/innovation-spotlight#.U2h8DfldUik

Zansors has been named a finalist at AARP Health Innovation @50+ LivePitch

We’re proud to announce that Zansors has been named a finalist at next month's AARP Health Innovation @50+ LivePitch!

The event, held during AARP's Life@50+ AARP National Event & Expo, features Zansors and nine peer companies that are poised to make an impact in healthcare for those 50 and over – and for everyone.

Read the press release here: http://health50.org/2014/04/01/aarp-livepitch-startup-health-tech-finalists-announced/